metformin has been researched along with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sayad, ME; El-Sisi, AE; Moussa, EA; Salim, EI; Sokar, SS | 1 |
| El-Sayad, M; El-Sisi, AE; Moussa, E; Salim, E; Sokar, S | 1 |
2 other study(ies) available for metformin and 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
| Article | Year |
|---|---|
Anticancer effect of metformin against 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine-induced rat mammary carcinogenesis is through AMPK pathway and modulation of oxidative stress markers.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Carcinogenesis; Carcinogens; Cholesterol; Female; Imidazoles; Insulin; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Metformin; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction | 2019 |
Metformin potentiates the chemotherapeutic effects of doxorubicin on 2-amino-1-methyl-6-phenylimidazo[4,5b] pyridine-induced Mammary Carcinoma in rats.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Drug Synergism; Female; Hypoglycemic Agents; Imidazoles; Mammary Neoplasms, Experimental; Metformin; Rats; Rats, Sprague-Dawley | 2021 |